
Naltrexone has long been FDA-approved for the treatment of alcohol use disorder, most commonly at doses around 50 mg, where it works by blocking opioid receptors and reducing alcohol cravings.
More recently, clinicians and researchers have turned their attention to low-dose naltrexone (LDN), typically around 1.5–4.5 mg daily, and its potential role in a wide range of chronic and inflammatory conditions. At these lower doses, naltrexone appears to work through different and more nuanced mechanisms, opening the door to new therapeutic possibilities.
At standard doses, naltrexone primarily functions as an opioid receptor antagonist. At low doses, however, research suggests it may temporarily block opioid receptors in a way that causes the body to increase its own production of endogenous opioids once the blockade lifts.
This rebound effect may help:
Because neuroinflammation and immune dysregulation play a role in many chronic illnesses, LDN has drawn interest across multiple specialties.
Low-dose naltrexone has been studied, or is actively being explored, for a variety of conditions, including:
Among these, fibromyalgia currently has some of the strongest supporting evidence for off-label LDN use.
Fibromyalgia affects millions of people and is often associated with widespread pain, fatigue, poor sleep, and cognitive difficulties (“brain fog”). Up to one-third of patients experience significant functional disability.
Studies suggest that low-dose naltrexone may:
These benefits make LDN an appealing option, especially for patients who struggle with side effects or limited effectiveness from standard therapies.
In Crohn’s disease, LDN has been shown to:
In multiple sclerosis, studies suggest improvements in:
Clinicians also report promising anecdotal outcomes in patients with post-COVID syndrome and POTS, where treatment options remain limited.
One of LDN’s biggest strengths is its safety profile.
Low-dose naltrexone is generally well tolerated. When side effects occur, they are typically mild and transient. The most commonly reported include:
These effects can often be managed by:
Serious adverse effects are uncommon.
Low-dose naltrexone usually requires a compounding pharmacy, which can limit access for some patients. Insurance coverage is inconsistent.
That said:
A commonly used dosing schedule is:
Dosing may be adjusted based on patient response and tolerability.
Beyond the studies, many clinicians report meaningful improvements in patients’ daily lives.
One patient with post-COVID syndrome and significant orthostatic symptoms had been forced to give up taekwondo due to fatigue and dizziness. After several months on low-dose naltrexone, he returned to training—and eventually began preparing to become a taekwondo instructor.
Stories like this highlight why interest in LDN continues to grow.
Low-dose naltrexone is not a cure-all. Its off-patent status makes large randomized controlled trials unlikely, which limits how quickly the evidence base can expand.
Still, based on current data and clinical experience, LDN stands out as:
As research continues, low-dose naltrexone may earn a more prominent place in modern, patient-centered care, proof that even older medications can find new life when viewed through a different lens.
At Better U, we believe in compassionate, evidence-based care that meets you where you are.
If you’re curious about the Sinclair Method or low-dose naltrexone, our licensed psychiatric providers can help you explore whether medication management is the right fit for your goals. We take a holistic psychiatry approach—meaning we look beyond prescriptions alone. That includes:
Whether you want to reduce drinking gradually or explore a broader mental health reset, you don’t have to figure it out alone.
Schedule a consultation with Better U today to learn how medication-assisted treatment and holistic psychiatric care can support sustainable, shame-free change.
Disclaimer: The content on this page is for informational and educational purposes only and is not medical or psychiatric advice. It does not create a patient–provider relationship and is not a substitute for consultation with a licensed clinician. Some treatments discussed (including holistic, weight management, sexual health, ketamine or other innovative therapies) may involve off‑label or non‑FDA‑approved uses and are not guaranteed to be safe, effective, or appropriate for you. Always talk with a qualified healthcare professional before making any changes to your care. Better U’s clinical team is available to provide personalized telemedicine appointments to determine which treatments, if any, may be appropriate for your individual situation.

Learn more about: What Is Low-Dose Naltrexone, and Can It Help Reduce Alcohol Use?


